Pharma leaders urge Europe to halt 'slow agony' of decline
Europe's top pharma firms have called on governments to take action to change the region's story from one of decay to one of "renewal and resilience."
Newsletters and Deep Dive digital magazine
Europe's top pharma firms have called on governments to take action to change the region's story from one of decay to one of "renewal and resilience."
GLP-1 treatments have historically had an exit problem, as appetite suppression stops when the medication stops.
The NIHR has revealed the first £45m in funding for projects that can bridge the translation gap in healthcare, focusing initially on community care.
UK Prime Minister Andy Burnham, who lost his father to Alzheimer's last week, has been urged to implement a "cancer-style" reform of dementia care.
Patients in the US with Sanfilippo syndrome type A have their first FDA-approved therapy, Ultragenyx Pharma's $3.9m one-shot gene therapy Fayuvi.
Editor's Picks
Newsletters and Deep Dive
digital magazine